Medinotec (MDNC) Non-Current Deferred Tax Liability (2024 - 2026)
Medinotec posted quarterly Non-Current Deferred Tax Liability of $80124.0 for Q1 2025, up 578.81% year-on-year from $11803.6 in Q1 2024, and up 578.81% on a QoQ basis from -$16734.0 in Q1 2024.
Medinotec (MDNC) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $80124.0 in Q1 2025.
- For the quarter ending Q1 2025, Non-Current Deferred Tax Liability rose 578.81% year-over-year to $80124.0; the trailing twelve-month figure through Feb 2025 stood at $80124.0 (up 578.81% YoY), and the FY2025 full-year result was $80124.0, up 578.81% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2025 stood at $80124.0, up from -$16734.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $80124.0 in Q1 2025 and bottomed at -$16734.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Medinotec | - | - | 854,557.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -3,478.00 |
| Feb 28, 2026 | -3,478.00 |
| Feb 28, 2025 | 80,124.00 |
| Feb 28, 2025 | 80,124.00 |
| Feb 29, 2024 | -16,734.00 |
| Feb 29, 2024 | -16,734.00 |